Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans.
Lefevre M, Racedo SM, Denayrolles M, Ripert G, Desfougères T, Lobach AR, Simon R, Pélerin F, Jüsten P, Urdaci MC.
Lefevre M, et al.
Regul Toxicol Pharmacol. 2017 Feb;83:54-65. doi: 10.1016/j.yrtph.2016.11.010. Epub 2016 Nov 5.
Regul Toxicol Pharmacol. 2017.
PMID: 27825987
Free article.
Clinical Trial.